MP R Weekly Dose 138 — Elahere Gets Accelerated Approval; Zejula Use Restricted; Update for IUD System; Interchangeable Insulin Products; Panel Votes on Tenapanor
MPR Weekly Dose18 Nov 2022

MP R Weekly Dose 138 — Elahere Gets Accelerated Approval; Zejula Use Restricted; Update for IUD System; Interchangeable Insulin Products; Panel Votes on Tenapanor

Newly approved gynecologic cancer treatment; Zejula has it's use restricted; intrauterine system use extended; a second insulin product is approved as a biosimilar to Lantus; and an FDA Advisory Committee take a vote on tenapanor.

Episoder(267)

Populært innen Helse

fastlegen
lydartikler-fra-aftenposten
rss-gukild-johaug
hvordan-har-du-det-mann
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-garne-damer
morten-ramm-lar-kakla-ga-til-du-sovner
foreldreradet
rss-lopedrommen
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
hormonelle-frida
klimaks
hjernesterk
rss-sunn-okonomi
g-punktet
helsetipspodden
sinnsyn
rss-kunsten-a-leve